A Type I allergy – which includes, for example, hay fever, allergic asthma or allergies to house dust, food and many other substances – occurs when the body produces antibodies of the immunoglobulin E (IgE) class in response to allergens (allergy-triggering substances). These are bound by IgE receptors on the surface of specialised immune cells in the body, known as mast cells. This leads to the release of inflammatory mediators such as histamine or leukotrienes and, subsequently, to the onset of allergic symptoms. To diagnose an allergy, in addition to taking a medical history, skin tests (prick tests, patch tests) are usually carried out; these can be uncomfortable and carry a risk of an allergic overreaction. Researchers have now developed a novel in vitro test using mature mast cells, which allows allergies to be detected simply and painlessly using patients’ serum samples. When allergens and immunoglobulins added to the serum encounter the corresponding receptors on the mast cells, the mast cells are activated. This stimulation can then be quantified relatively easily and quickly using a technique known as flow cytometry. To enable a large number of tests to be carried out, the researchers have already developed a high-throughput method that allows multiple allergens to be tested. The test can also be used to measure the success of immunotherapy. Furthermore, in clinical trials, it could be used to monitor the therapeutic success and duration of action of new allergy medicines, as well as to clarify unanswered questions in allergy research. Reference: University of Bern. A novel functional mast cell assay for the detection of allergies, JACI 2022; https://www.jacionline.org/article/S0091-6749(21)01246-
A new type of allergy test: painless and reliable